April 2 (Reuters) - Nuvo Pharmaceuticals Inc NRI.TO :
* NUVO PHARMACEUTICALS™ ANNOUNCES PENNSAID 2% MARKETING AUTHORIZATION APPLICATION ACCEPTED FOR REVIEW BY AGES, THE AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY
* NUVO PHARMACEUTICALS INC - MARKS FIRST EUROPEAN UNION SUBMISSION OF PENNSAID 2%
* NUVO PHARMACEUTICALS INC - ANTICIPATES A REVIEW OF DOSSIER AND DECISION TO TAKE PLACE OVER NEXT 12 TO 18 MONTHS